STOCKS TELEGRAPH

Author: Shimrez Hyder

  • China Hgs Real Estate Inc. (HGSH) Stock Surges Following Disclosure of Promising Q3 2021 Financial Reports

    China Hgs Real Estate Inc. (HGSH) stock prices stayed stable at USD$1.89 over the course of August 16th, 2021. Subsequent premarket fluctuations saw the stock surge by 8.47%, bringing the price per share up to USD$2.05.

    HGSH Stock’s Stellar Quarter     

    August 16th, 2021 saw HGSH stock announce its interim financial results for the first nine months of fiscal 2021. The leading regional real estate develop is headquartered in Hanzhong City, Shaanxi Province in China. The company reported a massive increase in revenues for the third quarter of fiscal 2021. The 2021 quarter reported USD$31.8 million, representing an increase of 944.6% as compared to the prior-year quarter. The third quarter of 2020 reported USD$3 million, with the year-over-year difference being largely attributed to more gross floor area sold during the current quarter.

    HGSH Stock’s Net Income Reports

    Net income for the third quarter of fiscal 2021 came in at roughly USD$3.6 million. HGSH stock reported a significant increase from the net loss it reported in the prior-year quarter, which amounted to roughly USD$2.6 million. Net income per share came out to USD$0.14 for the third quarter of fiscal 2021. This applies to both basic and diluted shares of the company’s common stock. This is comparable to the net loss per basic and diluted share of USD$0.11 in the third quarter of fiscal 2020.

    Nine-Month 2021 Breakdown

    Total revenues for the first nine months of fiscal 2021 came in at roughly USD$52.9 million. This is representative of a massive 630% increase in total revenues. Revenues for the first nine-month period of fiscal 2020 came in at USD$7.2 million. Net income was reported at almost USD$6.1 million for the first nine-month period of fiscal 2021. This is a significant improvement from the net loss of roughly USD$3.5 million reported in the prior-year period. Net income per share came out to USD$0.26 per both basic and diluted share for the first nine-month period of fiscal 2021. This is a massive improvement from the USD$0.15 net loss per basic and diluted share reported for the prior-year period.

    Future Outlook for HGSH Stock

    The company reported a promising quarter and is taking measures to continue its trajectory of success. HGSH stock is keen to facilitate significant and sustained increases in shareholder value. Management is leveraging the resources at its disposal to usher in organic growth.

  • Global-E Online Ltd. (GLBE) Stock Exhibits Minor Volatility Following Disclosure of Financial Reports for Q2 2021

    Global-E Online Ltd. (GLBE) stock prices were down by 2.53% as of the market closing on August 16th, 2021. This brought the price per share down to USD$68.28 at the end of the trading day. Subsequent premarket fluctuations saw the stock rally by 4.42%, bringing it up to USD$71.30.

    GLBE Stock Reports Strong Quarter

    The second quarter of fiscal 2021 saw GLBE stock publish record results. In conjunction with updated guidance for the rest of the year, the company’s continued momentum is evident. The trajectory of their success is further evidenced by a surplus of 90% growth in both Gross Merchandise Value and revenues. The quarter also saw a continued improvement in profitability, as well as the launch of several key clients. The company is concurrently executing its strategy, ranging from geographical expansion to the addition of features and innovative capabilities. The company is also continuing to expand its network of strategic partners in their ecosystem.

    Additional Financials

    Gross Merchandise Value was up 95% as compared to the prior year quarter, coming at USD$326. Revenues were up by 92%, coming in at USD$57.3 million. Of this total, Service fees comprised USD$21.1 million, while Fulfillment services revenue was reported at USD$36.2 million. Gross margin for the quarter was reported at 36%, up 360 basis points from the 32.4% reported in the second quarter of 2020. Adjusted EBITDA for Q2 2021 came out to USD$7.6 million, as compared to the USD$3.1 million reported in Q2 2020.

    GLBE Stock’s Comprehensive Growth

    GLBE stock reported outperforming across all of its business lines, with Service fees revenue leading with a 104% increase that constituted 37% of all revenues. Fulfillment fees grew by 85% as compared to the prior year quarter. The company reported the continued penetration of the United States market, with US outbound revenues increasing by 131% year over year.

    Continued Expansion

    The company is on schedule with the execution of the rollout of its newly established exclusive strategic partnership with Spotify. Shopify-based merchants are continuing to sign up and go live on an on-going basis. The company is working with Spotify to facilitate a more comprehensive integration of Global-e’s offering into Shopify’s platform and checkout.

    Future Outlook for GLBE Stock

    GLBE stock reported a promising quarter, rife with developments that will result in new opportunities for the business. The company is keen to leverage the resources at its disposal to usher in organic growth over the long term. Investors are hopeful that management will be able to facilitate significant and sustained increases in shareholder value.

  • NRX Pharma Inc. (NRXP) Stock Volatile Following the Disclosure of Q2 2021 Financial Reports

    NRX Pharma Inc. (NRXP) stock prices were down by 6.37% as of the market closing on August 16th, 2021. This brought the price per share down to USD$14.25 at the end of the trading day. Subsequent premarket fluctuations have seen the stock rally by 5.26%, bringing it up to USD$15.00.

    NRXP Stock’s Regulatory Filing

    A majority of the primary clinical activities reported during the second quarter of fiscal 2021 centered around analysis and regulatory filing. The company filed data from its phase 2b/3 clinical trial of intravenous ZYESAMI for Covid-19 Respiratory Failure. The quarter also saw NRXP stock support its NIH-sponsored ACTIV3b Critical Care study of ZYESAMI as compared to isolated use and in combination with Veklury. Furthermore, the company reported supporting its BARDA-sponsored I-SPY trial of inhaled ZEYSAMI, as well as the NRx-sponsored trial of inhaled ZYESAMI.

    Ramping Up Production

    In regard to manufacturing, NRXP stock focused on the development of its first shelf-stable formulation of ZYESAMI. This was announced early in the third quarter of 2021, along with involvement in scaling up aviptadil drug substance. The scaling is set to increase 100,000 doses per manufacturing batch to an anticipated 3 million doses per batch. This will be combined with a 90% reduction in the cost per gram of aviptadil drug substance.

    NRXP Stock’s Network of Partners

    The company has engaged in successful collaborative negotiations with the Israeli Institute for Biological Research. These negotiations have resulted in a long term partnership that was announced in Q3 of fiscal 2021. NRXP stock announced having entered into a collaborative agreement with TFF Pharma to develop a dry powder reconstitutable form of ZYESAMI. This form of the treatment has demonstrated initial room temperature stability. This technology has no shown promise for the development of a drug powder version of the BriLife vaccine.

    Addressing the Global Pandemic

    Nonclinical data has suggested the effectiveness of the treatment in neutralizing antibody response to Covid-19 and its variants, including the Delta variant. In conjunction with the rapidity with which the vaccine technology can be modified, new variants that may emerge are expected to be covered. NRXP stock also initiated business development interactions with MannKind Corp.. These interactions will see the company leverage the Technosphere platform for future inhaled use of ZYESAMI.

    Future Outlook for NRXP Stock

    NRXP stock reported a strong second quarter of fiscal 2021, with company management executing their strategy to continue their trajectory of success. Current and potential investors are hopeful that the company will be able to facilitate significant and sustained increases in shareholder value.

  • Roblox Corp. (RBLX) Stock Trending Lower Following Release of Q2 2021 Financial Reports

    Roblox Corp. (RBLX) stock prices were down by 5.23% as of the market closing on August 16th, 2021. This brought the price per share down to USD$79.57 at the end of the trading day. Subsequent premarket fluctuations saw the stock fall by 6.61%, bringing it down to USD$74.31.

    RBLX Stock’s Strong Financials

    The second quarter of fiscal 2021 saw RBLX stock report revenue in the amount of USD$454.1 million. This represents a 127% increase from revenues reported for the prior-year quarter. Net loss for Q2 2021 was reported at USD$140.1 million, despite bookings increasing by 35% since Q2 2020 to USD$665.5 million. Net cash provided by operating activities was up by 64% over the second quarter of 2020, coming in at USD$191.2 million. Free Cash Flow was up to USD$168 million, representing a 70% increase from numbers reported for Q2 2020.

    RBLX Stock’s Growing Usage

    Average Daily Active Users were reported at 43.2 million for the second quarter of fiscal 2021. The 29% year-over-year increase was largely driven by a 42% growth in DAUs outside of the US/Canada markets, as compared to Q2 2020. A 46% growth in DAUs over the age of 13, as compared to Q2 2020 reports, also facilitated the year-over-year increase. Q2 2021 saw RBLX stock report 9.7 billion hours engaged, representing a 13% year over year increase.

    Strength of July 2021

    DAUs for July 2021 alone were up to 46.6 million, representing a 28% year-over-year increase and an 8% increase on the 43.4 million reported in June 2021. The month reported 3.8 billion hours engaged, representing a 22% increase from Q2 2020 and a 16% increase on the 3.3 billion reported in June 2021. Bookings for the month ranged from USD$221 million to USD$224 million, representing a 19% to 21% year-over-year increase.

    Basis of RBLX Stock’s Growth

    The company’s continued growth indicated the competent execution of its business strategy, as well as the strength of its platform. The strong quarter was driven by its creator ecosystem, as well as by millions of its consumers around the globe. The quarter ended June 30th, 2021 saw RBLX stock report record levels of cash from operations and free cash flow.

    Future Outlook for RBLX

    RBLX stock reported a strong second quarter of fiscal 2021, with the company taking steps to ensure a continuation of their trajectory of success. Investors are hopeful that management will be able to usher in organic growth over the long term, resulting in consistent gains in shareholder value.

  • Danimer Scientific Inc. (DNMR) Stock Exhibits Volatility Following Disclosure of Q2 2021 Financial Reports

    Danimer Scientific Inc. (DNMR) stock prices were down 13.72% at the end of the trading day on August 16th, 2021. This brought the price per share down to USD$13.27. Subsequent premarket fluctuations saw the stock increase by 10.02%, bringing it up to USD$14.60.

    DNMR Stock’s Green Initiative

    The second quarter of fiscal 2021, saw DNMR stock make progress in its mission to create consumer packaging and other biodegradable products. This is in line with the company’s initiative to address the global plastic waste crisis. The team completed its Kentucky debottlenecking initiative to improve our production efficiency for Nodax based resins. The company substantially strengthened our capital resources to usher in further growth.

    Acquisition of Novomer

    August 2021 saw the company close its previously announced acquisition of Novomer Inc. The company expects the combination to accelerate the company’s ability to deliver their proprietary packaging products. These products are delivered to leading consumer product clients, serving as a milestone transaction for Danimer. The transaction is forecasted to create important efficiencies in our manufacturing of biodegradable polymers. The company expects this to help the company continue building its industry leading capabilities in application development.

    Scope of DNMR Stock’s Expansion

    The company is keen to leverage its competitive advantage, which is the result of its decade long experience blending products. This enables its next gen biopolymers to perform to the standards set by leading consumer product firms. The acquisition will strengthen DNMR stock’s core competence, as well as enabling an increase in the expected overall volume of finished product able to be delivered. These initiatives will be executed in conjunction with significant lowering of production costs and capital expenditure per pound produced.

    Revenue Breakdown

    Revenues for the second quarter of 2021 were up 22% to USD$14.5 million as compared to reports from the second quarter of 2020. This year over year difference was largely driven by the scale up of PHA production for Phase 1 of the Winchester facility, which was brought on line in 2020. PHA-based products expanded to 29% of total revenue, compared to 7% in the 2020 quarter. Q2 2021 also saw DNMR stock benefit from a USD$1.8 million increase in revenue related to R&D projects.

    Future Outlook for DNMR Stock

    The company reports a strong quarter, rife with various promising developments. The company is keen to leverage the resources at its disposal to usher in further growth. Investors are hopeful that management will be able to facilitate significant and sustained increases in shareholder value.

  • Niu Technologies (NIU) Stock on the Rise Following Disclosure of Promising Q2 2021 Financial Reports

    Niu Technologies (NIU) stock prices surged by 7.01% shortly after market trading commenced on August 16th, 2021. This brought the price per share up to USD$22.76 early on in the trading day.

    NIU Stock’s Sales Reports

    NIU stock reported a strong second quarter of fiscal 2021. China sales volume was up 58.8%, while international markets sales volume was up by 34.8% as compared to the prior year quarter. This improvement is despite persisting challenges with Covid-19 and international logistics. The company’s new F0 and F2 products have been well received by customers, serving to contribute to the volume growth. Online sales accounted for 21.4% of total sales volume and reach an all time high as a result of the launch of F0 through e-commerce platform.

    Additional Financials

    The company’s product mix also improved as compared to the previous quarter. Sales volumes from low-priced models G0 and F0 represented 30.4% of total sales volume. This is comparable to 38.2% in the first quarter of the fiscal 2021. Resultingly, revenues per e-scooter were up by 8.3% over reports from the previous quarter. July 2021 saw NIU stock deliver another new model C0, which was specifically designed to cater to a female demographic.

    Expansion of Product Portfolio

    Retail sales price for C0 model starts higher than price for both the G0 and the F0. The company also began the pre-sale of its newly launched kick-scooter, the KQi3 model. The product has been launched in both European and US markets, with delivery expected at the start of the fourth quarter of 2021.

    NIU Stock’s E-scooter Distribution

    The number of e-scooters sold over Q2 2021 reached 252,998, up 58% from reports from the prior year quarter. Sales of e-scooters in China were up 48.8% year over year, coming in at 246,018. E-scooter sales sold in international markets were reported at 6,980, representing a 34.8% year over year increase. The end of the second quarter of fiscal 2021 saw NIU stock report 2,366 franchised stores in China. This represents an addition of 450 stores since March 31st 2021.

    Future Outlook for NIU Stock

    NIU stock reported a strong second quarter of fiscal 2021, with the company hoping to continue its trajectory of success. The company is keen to set the stage for unprecedented growth as the global economy returns to prepandemic levels. Investors are hopeful for consistent gains in shareholder value over the long term.

  • FreightCar America Inc. (RAIL) Stock Surged Following Disclosure of Promising Financial Reports for Q2 2021

    FreightCar America Inc. (RAIL) stock prices were up 11.90% shortly after market trading commenced on August 16th, 2021. This brought the price per share down to USD$5.83 early on in the trading day.

    RAIL Stock’s Stellar H1 2021

    The second quarter of fiscal 2021 saw RAIL stock report having achieved the majority of its goals for the quarter. This included a third consecutive quarter of positive gross margin, positive operating income at the manufacturing level, and a solid mix of new business awarded. The first half of fiscal 2021 saw a reduction in adjusted EBITDA loss go down to USD$2 million. This is comparable to the USD$23.2 million Adjusted EBITDA loss in the second quarter of fiscal 2020. This year-over-year improvement reflects the massive scope of the company despite multiple supply chain constraints and significant raw material inflation.

    RAIL Stock’s Expansion

    RAIL stock is encouraged by signs indicating an improved demand environment across all of its end markets. Sales inquiries continue to remain positive, with guidance for the rest of 2021 having been raised for railcar deliveries. Furthermore, the company announced its Board of Directors having approved plans to add two more production lines at the Castenos manufacturing facility. This move is expected to double its capacity within a year. The planned expansion is a critical next step to facilitating increases in incremental volumes, as well as significantly improving our long-term earnings profile.

    Solid Liquidity Position

    The company is also benefitting from its relationship with its financial partner. This includes the recently amended agreement, according to which RAIL stock has a USD$25 million line of credit available to it. This line of credit, in conjunction with cash and cash equivalents in the amount of USD$21 million, indicate a solid liquidity position. These funds will support working capital and growth needs over the next several quarter.

    Consolidated Revenue Reports

    Consolidated revenues for the second quarter of 2021 came in at USD$37.4 million. This is comparable to the USD$32.4 million reported in the prior quarter and USD$17.5 million in the prior-year quarter. Q2 2021 saw the company deliver 313 railcars.

    Future Outlook for RAIL Stock

    The company reported a strong second quarter of fiscal 2021, with management continuing to take steps to continue its trajectory of success. RAIL stock is keen to leverage the resources at its disposal to usher in further organic growth. Investors are hopeful this will translate into significant and sustained increases in shareholder value.

  • ESSA Pharma Inc. (EPIX) Stock Plummets Following Disclosure of Financial Reports for Q2 2021

    ESSA Pharma Inc. (EPIX) stock prices plummeted by 31.46% shortly after market trading commenced on August 16th, 2021. This brought the price per share down to USD$8.17 early on in the trading day.

    EPIX Stock’s Collaboration

    April 28th 2021 saw EPIX stock announce its clinical collaboration with Bayer. The partnership is aimed at evaluating EPI-7386 in combination with Bayer’s androgen receptor inhibitor darolutamide. The study was conducted in patients with metastatic castration-resistant prostate cancer. As per the agreement, the partnering company may sponsor and conduct a Phase 1/2 EPI-7386 and darolutamide in mCRPC patients. EPIX stock will supply EPI-7386 for the trial, while retaining all rights to the treatment.

    EPIX Stock’s EPI-7386

    April 10th 2021 saw the company report new preclinical data on EPI-7386 at the 2021 American Association of Cancer Research Annual meeting. The presentation demonstrated that in vitro EPI-7386 can prevent the androgen receptor from binding to genomic DNA. The treatment was also demonstrated to inhibit AR related transcription in prostate cancer cell lines expressing androgen receptor (AR) splice variants, including the AR-v567es variant.

    Net Loss Reports

    Net loss for the second quarter of fiscal 2021 came in at USD$8.8 million. This represented a net loss of USD$0.21 per common share, on the basis of 31,018,024 weighted average common shares outstanding. This is comparable to the net loss of USD$4.9 million reported in the prior year quarter. This represented a net loss of USD$0.24 per common share, on the basis of 20,824,568 weighted average common shares outstanding. Reports for the 2021 quarter include non-cash share-based payments of USD$2.8 million, as compared for the USD$1.5 million reported in the prior year quarter. These payments were recognized for stock options granted and vesting.

    Strong Liquidity Position

    EPIX stock reported a strong liquidity position as of June 30th 2021, with cash reserves and short-term investments in the amount of USD$202.26 million. This reflects the generation of gross proceeds in February 2021 in the amount of USD$150 million. The raising of USD$48.9 in financing during July 2020 also contributed to this liquidity position, as did reduced operating expenses in the intervening period.

    Future Outlook for EPIX Stock

    EPIX stock reported a strong second quarter of fiscal 2021, with the company keen to leverage its cumulative resources resulting from its collaboration with Bayer. The company is taking steps to ensure the continuation of its trajectory of success. Investors are hoping for a recovery in shareholder value, followed by unprecedented and organic growth over the long term.

  • Data Storage Corp. (DTST) Stock on the Rise Following Promising Financial Reports for Q2 2021

    Data Storage Corp. (DTST) stock prices were up 3.17% shortly after market trading commenced on August 16th 2021. This brought the price per share up to USD$3.90 early on in the trading day.

    DTST Stock Revenue Report

    The second quarter of fiscal 2021 saw the company report a 76% increase in revenue as compared to the prior year quarter. DTST stock reported growth across all of its product lines, with forecasts of a continue trajectory of organic growth. The year over year increase is largely attributable to the increase in monthly subscription revenue and additions sales resulting from the Flagship Solutions merger.

    Acquisition of Flagship

    Flagship established itself as a leading provider of IBM solutions, managed services, and cloud solutions. The partnering company’s offerings and network of customers proved highly complementary to DTST stock. Notably, Q2 2021 revenue only included one month of results integrated with Flagship. The company expects substantial opportunities to cross-sell solutions across the joint partners’ respective clients. With the rest of the synergies gained from the acquisition, the company is keen to further facilitate operational efficiency across the business.

    Expansive Scope of DTST Stock

    With the expansion of product and service offerings as a result of the acquisition, DTST stock realigned its sales and marketing strategy. This changed focused more heavily on sports, banking and finance, healthcare, and government in a bid to drive organic growth. The company is well positioned to capitalize on the opportunities ahead of it. The target marketplace for Infrastructure as a Service and Disaster Recovery as a Service is pegged at more than one million logical partitions in the mission critical technical environment.

    Solid Liquidity Position

    The second quarter of 2021 reported the company significantly enhance its balance sheet. The quarter ended with DTST stock report USD$3.1 million in cash and cash equivalents. This is after payment for the acquisition of Flagship. Since the end of the quarter, the company has generated an additional USD$3.4 million in net proceeds for the exercise of warrants. DTST stock also raised USD$7.6 million through its registered direct offering in July 2021.

    Future Outlook for DTST Stock

    The company reported a strong second quarter of fiscal 2021, with management confident in the continuation of the trajectory of success. DTST stock is executing its strategy so as to adequately leverage its cumulative resources. Investors are hopeful that this will result in consistent increases in shareholder value.

  • GEE Group Inc. (JOB) Stock Surges Following Disclosure of Promising Financial Reports for Q3 2021

    GEE Group Inc. (JOB) stock prices were up 6.99% just before market trading commenced on August 16th, 2021. This brought the price per share up to USD$0.49 early on in the trading day.

    Strong Q3 2021 Financials

    The third quarter of fiscal 2021 saw JOB stock report USD$38.1 million in revenue. This is up 43.1% from the third quarter of the fiscal year 2021 and 9.6% from the second quarter of 2021. Income from operations came in at roughly USD$1.6 million, up USD$3.3 million from the net operating loss of almost USD$1.7 million for the prior year quarter. The Q3 2021 numbers were up USD$1 million from Q2 2021 period.

    Gross Profit and Margin

    Gross profit for the quarter came in at USD$13.8 million, representing a 43% year over year increase. The Q3 2021 numbers indicate growth in gross profit of 26.7% as compared to the previous quarter. Gross margins stayed relatively stable at 36.32% over the third quarters of 2020 and 2021. The Q3 2021 numbers were 490 basis points higher than the 31.4% reported in the prior quarter.

    JOB Stock’s Net Loss Reports

    Net loss attributable to common shareholder came in at negative USD$0.9 million for the third quarter of fiscal 2021. This represents a net loss per share of roughly USD$0.01 per diluted share. This is including the effects of net gains and losses on non recurring debt settlements, as well as interest on former high-cost debt being extinguished. The debt extinguishing amounted to roughly USD$2.5 million. Without these factors, net income available to common shareholders would come out to USD$1.6 million, or roughly USD$0.02 per diluted share.

    JOB Stock’s Liquidity Position

    The company reported a solid liquidity position of USD$7.4 million in cash and cash equivalents as of June 30th, 2021. As of the end of the quarter, shareholders’ equity came out to roughly USD$77.6 million. JOB stock reported full availability under its asset-backed bank revolving credit facility. The facility was valued at USD$20 million and had been closed for the quarter. No borrowings were outstanding as of June 30th, 2021, with roughly USD$13.1 million being available.

    Future Outlook for JOB

    JOB stock reported a strong third quarter of fiscal 2021, with the company keen to continue its trajectory of success. Current and potential investors are hopeful that management will be able to leverage the resources at their disposal. This is hoped to facilitate significant and sustained increases in shareholder value.